|
OKCA01120 |
Aviva Systems Biology |
96 Wells |
EUR 930 |
Description: Description of target: Transcriptional repressor mainly required for germinal center (GC) formation and antibody affinity maturation which has different mechanisms of action specific to the lineage and biological functions. Forms complexes with different corepressors and histone deacetylases to repress the transcriptional expression of different subsets of target genes. Represses its target genes by binding directly to the DNA sequence 5'-TTCCTAGAA-3' (BCL6-binding site) or indirectly by repressing the transcriptional activity of transcription factors. In GC B-cells, represses genes that function in differentiation, inflammation, apoptosis and cell cycle control, also autoregulates its transcriptional expression and up-regulates, indirectly, the expression of some genes important for GC reactions, such as AICDA, through the repression of microRNAs expression, like miR155. An important function is to allow GC B-cells to proliferate very rapidly in response to T-cell dependent antigens and tolerate the physiological DNA breaks required for immunglobulin class switch recombination and somatic hypermutation without inducing a p53/TP53-dependent apoptotic response. In follicular helper CD4+ T-cells (T(FH) cells), promotes the expression of T(FH)-related genes but inhibits the differentiation of T(H)1, T(H)2 and T(H)17 cells. Also required for the establishment and maintenance of immunological memory for both T- and B-cells. Suppresses macrophage proliferation through competition with STAT5 for STAT-binding motifs binding on certain target genes, such as CCL2 and CCND2. In response to genotoxic stress, controls cell cycle arrest in GC B-cells in both p53/TP53-dependedent and -independent manners. Besides, also controls neurogenesis through the alteration of the composition of NOTCH-dependent transcriptional complexes at selective NOTCH targets, such as HES5, including the recruitment of the deacetylase SIRT1 and resulting in an epigenetic silencing leading to neuronal differentiation.1;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sanadwich ELISA;Sensitivity: 4.68 pg/mL |
Aviva Systems Biology Laboratories manufactures the aviva bcl6 elisa reagents distributed by Genprice. The Aviva Bcl6 Elisa reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Aviva Systems Biology. Other Aviva products are available in stock. Specificity: Aviva Category: Bcl6 Group: Elisa
Sulfathiazole ELISA Kit (OKAO00107) |
Aviva Systems Biology |
96 Wells |
EUR 558 |
Description: Description of target: Sulfathiazole is a short-acting sulfonamide antibiotic. Its use has been largely replaced with less toxic alternatives but is still used in combination with sulfacetamide and sulfabenzamide for the treatment of vaginal infections and for disinfecting home aquariums.;Species reactivity: General;Application: ;Assay info: Assay Methodology: Competitive Inhibition ELISA;Sensitivity: Component | Amount |
---|
Tissue | 1 ppb | Honey | 1 ppb |
|
Sulfamethoxazole ELISA Kit (OKAO00108) |
Aviva Systems Biology |
96 Wells |
EUR 558 |
Description: Description of target: Sulfamethoxazole is a sulfonamide bacteriostatic antibiotic that is most commonly used in combination with trimethoprim as the drug Bactrim. Sulfamethoxazole competitively inhibits dihydropteroate synthase preventing the formation of dihydropteroic acid, a precursor of folic acid which is required for bacterial growth.;Species reactivity: General;Application: ;Assay info: Assay Methodology: Competitive Inhibition ELISA;Sensitivity: Component | Amount |
---|
Tissue(Method 1) | 0.1 ppb | Tissue(Method 2) | 1 ppb | Serum, Urine, Egg | 0.4 ppb | Honey | 0.1 ppb | Milk | 2 ppb | Feed | 4 ppb |
|
Sulfadimethoxine ELISA Kit (OKAO00109) |
Aviva Systems Biology |
96 Wells |
EUR 558 |
Description: Description of target: Sulfadimethoxine is a long-acting sulfonamide antibiotic used in veterinary medicine. Sulfadimethoxine inhibits bacterial synthesis of folic acid by competing with para-aminobenzoic acid (PABA) for the binding site on dihydropteroate synthase.;Species reactivity: General;Application: ;Assay info: Assay Methodology: Competitive Inhibition ELISA;Sensitivity: Component | Amount | _x000D_Tissue | 1 ppb | _x000D_Honey | 1 ppb | _x000D_Serum | 4 ppb | _x000D_Milk | 20 ppb | _x000D_
|
Sulphadimidine ELISA Kit (OKAO00110) |
Aviva Systems Biology |
96 Wells |
EUR 532 |
Description: Description of target: Sulfamethazine is a sulfanilamide anti-infective agent. It has a spectrum of antimicrobial action similar to other sulfonamides.;Species reactivity: General;Application: ;Assay info: Assay Methodology: Competitive Inhibition ELISA;Sensitivity: Component | Amount |
---|
Tissue(Method 1) | 0.5 ppb | Tissue(Method 2) | 2.5 ppb | Serum, Urine | 2 ppb | Honey | 0.1 ppb | Milk | 2 ppb |
|
Ciprofloxacin ELISA Kit (OKAO00115) |
Aviva Systems Biology |
96 Wells |
EUR 532 |
Description: Description of target: Ciprofloxacin is a synthetic broad spectrum fluoroquinolone antibiotic. Ciprofloxacin binds to and inhibits bacterial DNA gyrase, an enzyme essential for DNA replication. This agent is more active against Gram-negative bacteria than Gram-positive bacteria.;Species reactivity: General;Application: ;Assay info: Assay Methodology: Competitive Inhibition ELISA;Sensitivity: Component | Amount |
---|
Tissue | 1 ppb | Honey | 1 ppb |
|
Enrofloxacin ELISA Kit (OKAO00116) |
Aviva Systems Biology |
96 Wells |
EUR 532 |
Description: Description of target: Enrofloxacin (ENR) is a fluoroquinolone antibiotic sold by the Bayer Corporation under the trade name Baytril. Enrofloxacin is currently approved by the FDA for the treatment of individual pets and domestic animals in the United States. In September 2005, the FDA withdrew approval of Baytril for use in water to treat flocks of poultry, as this practice was noted to promote the evolution of fluoroquinolone-resistant strains of the bacterium Campylobacter, a human pathogen.;Species reactivity: General;Application: ;Assay info: Assay Methodology: Competitive Inhibition ELISA;Sensitivity: Component | Amount |
---|
Tissue | 1 ppb | Honey | 1 ppb |
|
Clenbuterol ELISA Kit (OKAO00117) |
Aviva Systems Biology |
96 Wells |
EUR 532 |
Description: Description of target: Clenbuterol is a substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.;Species reactivity: General;Application: ;Assay info: Assay Methodology: Competitive Inhibition ELISA;Sensitivity: Component | Amount |
---|
Urine | 0.05 ppb | Tissue(1) | 0.2 ppb | Tissue(2) | 0.05 ppb | Feed | 0.5 ppb |
|
Elisa information
BCL6 Antibody |
1-CSB-PA040220 |
Cusabio |
|
|
- Form: Liquid
- Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
|
Description: A polyclonal antibody against BCL6. Recognizes BCL6 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/10000 |
BCL6 Antibody |
1-CSB-PA040221 |
Cusabio |
|
|
- Form: Liquid
- Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
|
Description: A polyclonal antibody against BCL6. Recognizes BCL6 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/40000 |
BCL6 Antibody |
1-CSB-PA171912 |
Cusabio |
|
|
- Form: Liquid
- Buffer: -20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol Antigen affinity purification
|
Description: A polyclonal antibody against BCL6. Recognizes BCL6 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100 |
Bcl6 antibody |
70R-34469 |
Fitzgerald |
100 ug |
EUR 327 |
Description: Rabbit polyclonal Bcl6 antibody |
BCL6 siRNA |
20-abx908994 |
Abbexa |
|
|
- Shipped within 5-10 working days.
|
BCL6 siRNA |
20-abx908995 |
Abbexa |
|
|
- Shipped within 5-10 working days.
|
BCL6 Blocking Peptide |
33R-10747 |
Fitzgerald |
50 ug |
EUR 191 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of BCL6 antibody, catalog no. 70R-11805 |
Bcl6 Blocking Peptide |
DF2903-BP |
Affbiotech |
1mg |
EUR 195 |
Bcl6 antibody (Ser333) |
70R-34468 |
Fitzgerald |
100 ug |
EUR 327 |
Description: Rabbit polyclonal Bcl6 antibody (Ser333) |
Anti-BCL6 Antibody |
A00142-1 |
BosterBio |
100ug/vial |
EUR 334 |
BCL6 (pS333) Antibody |
20-abx121849 |
Abbexa |
-
EUR 314.00
-
EUR 467.00
-
EUR 203.00
|
|
- Shipped within 5-10 working days.
|
BCL6 Blocking Peptide |
20-abx161029 |
Abbexa |
|
|
- Shipped within 5-10 working days.
|
BCL6 Blocking Peptide |
20-abx161304 |
Abbexa |
|
|
- Shipped within 5-10 working days.
|
BCL6 Blocking Peptide |
20-abx162090 |
Abbexa |
|
|
- Shipped within 5-10 working days.
|
BCL6 Conjugated Antibody |
C37150 |
SAB |
100ul |
EUR 397 |